Wuhan Ammunition Life-tech Co.,ltd. was established in January 2015. It is a high-tech enterprise focusing on the research and development, registration, production and sales of early non-invasive detection products for high-incidence malignant tumors in the world. The company headquarters, research and development center, manufacturing center and medical testing laboratory The room is located in Wuhan Optics Valley Biological City.
As one of the world's leading companies in the new generation of early cancer screening and early diagnosis products, Emerson is committed to the global promotion of early cancer diagnosis technology products, combining epigenetics, bioinformatics, clinical big data and artificial intelligence analysis, upholding the ' The product concept of 'Early, Accurate, Convenient, and Inclusive' has created a new generation of tumor screening and detection technology platform and product system, and has launched a series of high-incidence cancers covering digestive system tumors, gynecological tumors, urinary system tumors and pan-cancer types. The early non-invasive detection products of tumors truly realize the early, non-invasive and accurate detection of tumors, which fundamentally reduces the morbidity and mortality of tumors, stifles cancer in the bud, and escorts human life and health.